Go to content
Logo Medicines Evaluation Board
You are here: Home
  • Medicines Information Bank
  • Veterinary Medicines Information Bank

Main menu

  • Marketing authorisation medicines for human use

    Procedures, dossier requirements, pharmacovigilance, policy

  • Veterinary Medicinal Products Unit

    Marketing authorisation, reporting adverse events, production, distribution

  • About MEB

    Our story, our work, the organisation, working at the MEB, contact

Home

News

DCP time slot tool temporarily switched off

21-12-2020 | 10:00

Due to security precautions, the MEB has had to switch off the DCP time slot planning tool.

MEB Science Day 2021 – Registration is now open!

17-12-2020 | 17:00

Earlier the Medicines Evaluation Board announced the next MEB Science Day ‘The evolution of 25 years of Pharmacovigilance’ on 18 ...

Regulatory Science Magazine 11 on monitoring corona vaccines

19-10-2020 | 17:00

The eleventh edition of the MEB’s Regulatory Science Magazine brings you interviews with Peter Mol, professor of Drug Regulatory ...

Year-end withdrawals medicines for human use

01-09-2020 | 09:00

Requests to withdraw marketing authorisations and parallel import marketing authorisations as of 31 December 2020, the so-called ...

Conclusion of report: paracetamol is safe to use

26-08-2020 | 10:00

Patients and consumers can continue to use paracetamol safely in the Netherlands. This is the conclusion of the Netherlands ...

Safety of paracetamol is not compromised

09-07-2020 | 22:30

Tonight (Thursday July 9) the Dutch newspaper NRC and TV programme Zembla published an article on contamination of paracetamol ...

More news
ISO 9001:2015
Good medicines used better.

Service

  • Contact
  • Working at the MEB
  • Sitemap
  • Help
  • Archive
  • Subscribe

About this site

  • Copyright
  • Privacy
  • Cookies
  • Accessibility
  • Report vulnerability
  • Nederlands